Delivery Order SPE2DP18D0011-SPE2DP18F5957
Award Date
9/21/18
Potential Completion Date
9/23/19
Potential Value
$469K
Federal Agency
Medical Supply Chain
Awardee
Genentech Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Genentech USA, Inc., a biotechnology company that manufactures pharmaceutical products, for the supply of the antiviral medication Oseltamivir Phosphate. The $179,992.80 contract has a completion date of September 23, 2019 and does not utilize any set-asides. Genentech, as the prime contractor, will perform the work at its facility in South San Francisco, California. This delivery order is part of...
This $342,870.90 firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company that manufactures pharmaceuticals. The contract is for the antiviral drug oseltamivir phospha and does not utilize any set-aside designation. Genentech has provided a variety of biologic medicines to government agencies through multiple federal contract vehicles, including the Pharmaceuticals and Drugs Federal Supply Schedule. This...
The Defense Logistics Agency Troop Support Medical awarded a $4,343,441.64 firm fixed price delivery order to Genentech USA, Inc. for the purchase of the antiviral medication oseltamivir phosphate. This order was placed against an existing indefinite delivery contract with the biotechnology manufacturer, which has a history of providing various pharmaceutical products to federal agencies such as the Departments of Health and Human Services, Defense, Justice, and Veterans Affairs. Genentech...
The Department of Defense's Defense Logistics Agency Troop Support Medical awarded a $121,129.77 firm fixed-price delivery order to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of the antiviral drug Oseltamivir Phospha. This order was placed under an existing contract vehicle and will support the delivery of the medication to government locations in South San Francisco, California by September 24, 2019. Genentech holds various indefinite delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics. The contract is for the supply of oseltamivir phosphate, an antiviral medication, with a total ceiling value of $259,393.47. The contract is a firm-fixed price delivery order with a completion date of September 20, 2017. Genentech is the prime contractor, and no major subcontractors were identified. The contract is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of oseltamivir phosphate, an antiviral medication. The contract has a firm fixed price, with a ceiling value of $88,842.60, and was awarded on September 8, 2017 with a completion date of September 10, 2018. The contract was not set aside for any special designation. Genentech holds several key contract vehicles with...
The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Genentech USA, Inc., a foreign-owned for-profit manufacturer of pharmaceuticals, to provide the antiviral medication Oseltamivir Phosphate. The $150,724.74 contract has a completion date of September 24, 2019 and is not designated as a set-aside. Genentech, which has supplied various drugs to U.S. government agencies through indefinite delivery contracts and Federal Supply Schedules, will...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology company. The $93,573.18 firm-fixed-price contract is for the delivery of oseltamivir phosphate, an antiviral medication. The award falls under a larger indefinite delivery contract between Genentech and DLA valued at $27.9 million to supply medical supplies and critical pharmaceuticals for the Department of Defense. No set-aside designation was used....
This is a delivery order (SPE2DP16D0008|0041) awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals. The $9,862,682.40 firm-fixed-price contract is for the delivery of oseltamivir phosphate, an antiviral medication, to support the federal government's medical supply needs. The contract does not have a set-aside designation. Genentech holds several key contract vehicles with federal...
This federal contract award, SPE2DP16D0008|0051, was issued by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $76,496.94 firm-fixed-price delivery order is for the supply of oseltamivir phosphate, an antiviral medication, with a period of performance through September 11, 2018. Genentech holds several major contract vehicles with federal agencies like the Department of Veterans Affairs and the Department...